Damora Therapeutics, Inc. (DMRA) Presents at UBS Global Biopharma Conference 2026 Transcript
UBS shows meaningful earnings recovery, with net interest income rising from roughly $1.4B in 2024Q2 to $2.3B in 2026Q3 and the efficiency ratio clustering near 72 to 73 percent in recent quarters, suggesting integration cost synergies may be partially realized.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Net interest income climbed about 64 percent from 2024Q2 to 2026Q3 while the efficiency ratio improved to roughly 72.7 percent, suggesting cost progress is real even as revenue flattens.
UBS is projected to achieve the fastest sequential earnings per share growth among global banks, with a 30% increase expected between 2025 and 2028. In 2025, the bank’s revenue rose 3.26% to $49.60 billion, while earnings surged 52.74% to $7.77 billion.
UBS’s Asset Management segment serves high‑net‑worth clients and has surpassed $2 trillion in invested assets, providing a solid and growing revenue stream.
The successful integration of Credit Suisse is expected to lift margins and unlock long‑term earnings power through efficiency gains, a critical test of UBS’s strategy.
Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 28, 2026 | $0.85-6.6% vs $0.91 | $13.4B+2.4% vs $13.1B |
Q3 2026 Jul 29, 2026 | $0.87-3.3% vs $0.90 | $13.3B-0.4% vs $13.4B |
Q2 2026 Apr 29, 2026 | $0.94+10.6% vs $0.85 | $13.6B+3.7% vs $13.2B |
Q1 2026 Feb 4, 2026 | $0.37-31.7% vs $0.54 | $12.2B+4.2% vs $11.7B |
Damora Therapeutics, Inc. (DMRA) Presents at UBS Global Biopharma Conference 2026 Transcript
UBS set to accept defeat over Swiss capital curbs, sources say
MANCHESTER, N.H., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced that the company will present at two upcoming conferences.
NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced that its senior leadership team will be participating in a fireside chat at the 2026 UBS Global Industrials & Transportation Conference on Tuesday, December 1 at 3:30 p.m. ET. A live webcast link and archived replay will be available in the “Events” area on the Investor Relations page of APi's website at APi Group Investor Relations - Events. Interested parties should check the C.
Benchmark UBS against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for UBS Group AG (UBS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $46.56 | $152.61B | 15.27 | 13.72% | 18.31% | 10.67% | 1.48% | |
| $183.53 | $289.48B | 14.00 | 14.48% | 25.97% | 17.7% | 2.26% | |
| $877.52 | $264.22B | 11.92 | 8.92% | 31.81% | 17.9% | 1.89% | |
| $49.44 | $350.86B | 11.26 | 11% | 26.12% | 10.69% | 2.56% | |
| $119.94 | $205.69B | 10.59 | 5.09% | 20.8% | 9.07% | 2.4% | |
| $329.96 | $884.13B | 13.42 | 7.32% | 32.48% | 17.91% | 1.81% |
UBS Group AG (UBS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when UBS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
UBS Group AG (UBS) stock FAQ — growth, dividends, profitability & financials explained
UBS Group AG (UBS) grew revenue by 16.0% over the trailing twelve months, compared with the twelve months before.
Yes. UBS Group AG (UBS) earned $9.65B in net income over the trailing twelve months (a 18.3% net margin).
Yes. UBS Group AG (UBS) pays a dividend that yields 1.48% at the current price, a moderate yield.
UBS Group AG (UBS) had a return on equity (ROE) of 10.7% over the trailing twelve months. That is in line with the market's typical 10-15%.
UBS Group AG (UBS) has a net interest margin (NIM) of 0.5%. NIM has been under pressure due to interest rate environment.
UBS Group AG (UBS) has an efficiency ratio of 80.2%. This is higher than peers, suggesting room for cost optimization.